- Home
- KMDA vs ACRE Comparison
KMDA vs ACRE Comparison
Compare KMDA & ACRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- ACRE
- Stock Information
- Founded
- KMDA 1990
- ACRE 2011
- Country
- KMDA Israel
- ACRE United States
- Employees
- KMDA N/A
- ACRE N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- ACRE Real Estate Investment Trusts
- Sector
- KMDA Health Care
- ACRE Real Estate
- Exchange
- KMDA Nasdaq
- ACRE Nasdaq
- Market Cap
- KMDA 349.6M
- ACRE 337.1M
- IPO Year
- KMDA N/A
- ACRE 2012
- Fundamental
- Price
- KMDA $7.16
- ACRE $5.93
- Analyst Decision
- KMDA Strong Buy
- ACRE Hold
- Analyst Count
- KMDA 2
- ACRE 7
- Target Price
- KMDA $14.50
- ACRE $6.90
- AVG Volume (30 Days)
- KMDA 142.0K
- ACRE 844.6K
- Earning Date
- KMDA 03-05-2025
- ACRE 02-20-2025
- Dividend Yield
- KMDA N/A
- ACRE 16.86%
- EPS Growth
- KMDA 124.29
- ACRE N/A
- EPS
- KMDA 0.27
- ACRE N/A
- Revenue
- KMDA $158,380,000.00
- ACRE $39,423,000.00
- Revenue This Year
- KMDA $15.81
- ACRE N/A
- Revenue Next Year
- KMDA $5.79
- ACRE N/A
- P/E Ratio
- KMDA $26.36
- ACRE N/A
- Revenue Growth
- KMDA 4.52
- ACRE N/A
- 52 Week Low
- KMDA $4.74
- ACRE $5.33
- 52 Week High
- KMDA $8.00
- ACRE $10.53
- Technical
- Relative Strength Index (RSI)
- KMDA 70.04
- ACRE 43.89
- Support Level
- KMDA $7.00
- ACRE $5.33
- Resistance Level
- KMDA $8.00
- ACRE $5.93
- Average True Range (ATR)
- KMDA 0.31
- ACRE 0.20
- MACD
- KMDA 0.06
- ACRE 0.01
- Stochastic Oscillator
- KMDA 60.93
- ACRE 64.67
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About ACRE Ares Commercial Real Estate Corporation
Ares Commercial Real Estate Corp is a specialty finance company and a Real Estate Investment Trust providing commercial real estate loans and related investments. It operates in one segment namely originating and managing a diversified portfolio of CRE debt-related investments. The group recognizes its revenues through the interest income it receives from loans.